+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Multiple Sclerosis: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Multiple Sclerosis: Dynamic Market Forecast to 2026

  • Report
  • November 2018
  • 53 Pages
  • Global
From
Implantable Drug Delivery Devices Global Market Report 2024 - Product Thumbnail Image

Implantable Drug Delivery Devices Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
From
Biobetters Market - Growth, Trends, and Forecast(2022 - 2027) - Product Thumbnail Image

Biobetters Market - Growth, Trends, and Forecast(2022 - 2027)

  • Report
  • January 2022
  • 115 Pages
  • Global
From
Anti-Cancer MAbS Global Market Report 2024 - Product Thumbnail Image

Anti-Cancer MAbS Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Antiglaucoma Drugs Global Market Report 2024 - Product Thumbnail Image

Antiglaucoma Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
From
Geographic Atrophy (GA) - Pipeline Insight, 2024 - Product Thumbnail Image

Geographic Atrophy (GA) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Choroidal Neovascularization - Pipeline Insight, 2024 - Product Thumbnail Image

Choroidal Neovascularization - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator